Live Breaking News & Updates on Mathilde Bohin|Page 16

Stay updated with breaking news from Mathilde bohin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Implanet's Annual General Meeting on the Second Call Will Be Held on June 9, 2022 at 2 pm CEST

Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans), a medical technology company specializing in vertebral implants, informs its shareholders ....

United States , France General , Arthur Rouill , F Magendie Technopole Bordeaux , Mathilde Bohin , Nicolas Fossiez , David Dieumegard , Ludovic Lastennet , Orthopaedic Spine Development , Company On , Drug Administration , Regulatory News , Euronext Growth , Annual General Meeting , Technopole Bordeaux Montesquieu , Thursday June , Investor Relations ,

GeNeuro: Availability of Documents and Information for the Annual Shareholders' Meeting of May 31, 2022

Regulatory News: GeNeuro (Euronext Paris: CH0308403085 GNRO) (Paris:GNRO), a biopharmaceutical company developing treatments for neurodegenerative and autoimmune diseases, such as multiple sclerosis ....

France General , Plan Les Ouates , Arthur Rouill , Mathilde Bohin , Louis Victor Delouvrier , Feuille Officielle Suisse , Regulatory News , Euronext Paris , General Meeting , Tuesday May , Ordinary General Meeting , Investors Documentation Shareholders ,

GeNeuro Publishes Its 2021 Universal Registration Document

GeNeuro Publishes Its 2021 Universal Registration Document
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

France General , Arthur Rouill , Louis Victor Delouvrier Mathilde Bohin , Euronext Paris , Registration Document , Des March , Annual Shareholder Meeting , Victor Delouvrier , Mathilde Bohin ,

IMPLANET Reports Q1 2022 Revenue

Q1 2022 revenue doubles to €2.02 million (vs. Q1 2021), driven by the organic growth of its JAZZ activity and the strategic acquisition of OSD Acceleration in activity in France (x2.7) and ....

United States , France General , Mathilde Bohin , Nicolas Fossiez , Nicolas Merigeau , David Dieumegard , Ludovic Lastennet , Orthopaedic Spine Development , Drug Administration , Euronext Growth , General Meeting ,

Oncodesign Confirms Its Very Good Results in 2021 and an Attractive Outlook For 2022

Group turnover up by 23% at €31.3 millionOperating income and revenue of €36.2M, offsetting the foreseen discontinuation of the GSK subsidy (€8M)R&D investments amounting to €7.4MNet profit/loss near the break-even point (-€0.3M)Service BU:Very strong organic growth in external turnover at +31%, reaching €27.6M,EBIT. ....

United States , France General , Arnaud Lafforgue , Mathilde Bohin , Les Ulis , Philippe Genne , University Hospital , Investments In Research , Research Tax Credit , Oncodesign Group , Business Development , Regulatory News , Business Units , Artificial Intelligence , Chief Financial Officer , North American , Drug Discovery , Statutory Auditor , Euronext Growth Market ,